RARE Ultragenyx Pharmaceutical Inc. - Common Stock

NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗

$23,59

Prezzo · Mag 20, 2026

Fondamentali al Mag 6, 2026

Margine di Profitto Netto

-85.4%

RARE Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

Prezzo

$23.59

Capitalizzazione di Mercato

$2.22B

P/E (TTM)

-3.9

EPS (TTM)

$-5.83

Ricavi (TTM)

$673M

Rendimento div.

—

ROE

-1613.2%

D/E Debito/Patrimonio

—

Intervallo 52 sett.

$18 – $42

RARE Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Ricavi e Utile Netto $673M

2016-12-31 → 2025-12-31

EPS $-5.83

2020-12-31 → 2025-12-31

Flusso di cassa libero $-472M

2016-12-31 → 2025-12-31

Margini -85.4%

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica

Tendenza 5 anni

RARE

Mediana dei peer

P/E (TTM)

-3.9

28.7

P/S (TTM)

3.3

14.1

P/B

-27.8

4.0

Price / FCF (Prezzo / FCF)

-4.7

—

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica

Tendenza 5 anni

RARE

Mediana dei peer

Operating Margin (Margine Operativo)

-79.5%

—

Net Profit Margin (Margine di Profitto Netto)

-85.4%

-39.7%

ROA

-37.9%

-24.1%

ROE

-1613.2%

-33.3%

ROIC

673.4%

—

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica

Tendenza 5 anni

RARE

Mediana dei peer

Current Ratio (Rapporto corrente)

2.5

12.3

Quick Ratio

1.5

—

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica

Tendenza 5 anni

RARE

Mediana dei peer

Revenue YoY (Ricavi YoY)

20.2%

—

Revenue CAGR 3Y (CAGR Ricavi 3Y)

22.8%

—

Revenue CAGR 5Y (CAGR Ricavi 5Y)

20.0%

—

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica

Tendenza 5 anni

RARE

Mediana dei peer

EPS (Diluted) (EPS (Diluito))

$-5.83

—

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica

Tendenza 5 anni

RARE

Mediana dei peer

RARE Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

COMPRA 26 analisti

Acquisto forte 8 30,8%
Compra 15 57,7%
Mantieni 3 11,5%
Vendi 0 0,0%
Vendita forte 0 0,0%

Target Price a 12 Mesi

19 analisti · 2026-05-16

Mediana $48.00

← Sotto tutti i target $23.59

Basso $25.00

Alto $84.00

Target mediano $48.00 +103,5%

Target medio $51.53 +118,4%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Sorpresa media

-0.16%

Periodo	EPS Actual	EPS Stimato	Sorpresa
31 Marzo 2026	$-1.84	$-1.54	-0.30%
31 Dicembre 2025	$-1.29	$-1.11	-0.18%
30 Settembre 2025	$-1.81	$-1.26	-0.55%
30 Giugno 2025	$-1.17	$-1.32	0.15%
31 Marzo 2025	$-1.57	$-1.65	0.08%

Confronto tra pari Metriche chiave rispetto ai pari del settore

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
RARE	$2.22B	-3.9	20.2%	-85.4%	-1613.2%	—
RLAY	$1.47B	-5.3	53.4%	-1800.6%	-44.9%	—
IRON	$3.01B	-13.2	—	—	-31.3%	—
CLDX	$1.81B	-7.0	-78.0%	-16748.0%	-43.8%	—
VERA	—	-10.9	—	—	-55.9%	—
IMNM	$2.43B	-8.8	-23.2%	-3060.0%	-47.0%	—
MLYS	$2.96B	-15.8	—	—	-32.2%	—
KOD	$1.73B	-6.5	—	—	-202.0%	—
BCRX	$1.66B	6.4	94.1%	30.2%	-97.6%	—
TYRA	$1.41B	-13.1	—	—	-42.7%	—

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Conto Economico 16

Dati annuali Conto Economico per RARE
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Revenue	$673M	$560M	$434M	$363M	$351M	$271M	$104M	$51M	$3M	$133.0K
Cost of Revenue	·	·	·	·	·	·	·	$1M	$1.0K	·
R&D Expense	$750M	$698M	$648M	$706M	$497M	$412M	$357M	$294M	$232M	$183M
SG&A Expense	$349M	$321M	$310M	$278M	$220M	$183M	$162M	$128M	$100M	$65M
Operating Expenses	·	·	·	·	·	$601M	$528M	$423M	$332M	$248M
Operating Income	$-535M	$-536M	$-569M	$-649M	$-382M	$-330M	$-424M	$-371M	$-329M	$-248M
Interest Income	$25M	$37M	$27M	$11M	$2M	$7M	$13M	$10M	$4M	$4M
Other Non-op	$1M	$-5M	$-1M	$-2M	$-2M	$607.0K	$-787.0K	$-6M	$7M	$-2M
Pretax Income	$-571M	$-567M	$-609M	$-702M	$-453M	$-185M	$-399M	$-197M	$-318M	$-246M
Income Tax	$4M	$2M	$-2M	$6M	$1M	$1M	$3M	$514.0K	$-16M	$35.0K
Net Income	$-575M	$-569M	$-607M	$-707M	$-454M	$-187M	$-403M	$-198M	$-302M	$-246M
EPS (Basic)	$-5.83	$-6.29	$-8.25	$-10.12	$-6.70	$-3.07	·	·	·	·
EPS (Diluted)	$-5.83	$-6.29	$-8.25	$-10.12	$-6.70	$-3.07	·	·	·	·
Shares (Basic)	98,600,000	90,500,000	73,500,000	69,914,225	67,795,540	60,845,550	·	·	·	·
Shares (Diluted)	98,600,000	90,500,000	73,500,000	69,914,225	67,795,540	60,845,550	·	·	·	·
EBITDA	$-500M	$-500M	$-543M	$-631M	$-368M	$-318M	$-416M	$-352M	$-323M	$-245M

Stato Patrimoniale 29

Dati annuali Stato Patrimoniale per RARE
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Cash & Equivalents	$421M	$174M	$214M	$133M	$308M	$714M	$434M	$113M	$100M	$161M
Short-term Investments	·	·	·	·	·	·	$322M	$346M	$134M	$219M
Receivables	$158M	$122M	$73M	$40M	$28M	$23M	$33M	$13M	$5M	·
Inventory	$52M	$45M	$34M	$27M	$16M	$13M	$12M	$7M	$757.0K	·
Prepaid Expense	$61M	$40M	$48M	$69M	$72M	$58M	$51M	$43M	$29M	$20M
Other Current Assets	·	·	$48M	$69M	·	·	·	·	·	·
Current Assets	$951M	$817M	$732M	$884M	$857M	$1.30B	$851M	$522M	$270M	$402M
PP&E (Net)	$244M	$266M	$291M	$260M	$141M	$74M	$44M	$20M	$22M	$17M
PP&E (Gross)	$380M	$378M	$374M	$323M	$191M	$111M	$70M	$38M	$33M	$23M
Accum. Depreciation	$136M	$112M	$83M	$63M	$50M	$37M	$26M	$18M	$11M	$6M
Goodwill	$44M	$44M	$44M	$44M	$44M	$44M	$44M	$44M	$44M	·
Intangibles	$176M	$178M	$166M	$160M	$131M	$131M	$129M	$129M	$142M	·
Other Non-current Assets	$60M	$63M	$58M	$48M	$21M	$9M	$3M	$4M	$3M	$2M
Total Assets	$1.53B	$1.50B	$1.49B	$1.55B	$1.52B	$1.76B	$1.14B	$720M	$491M	$541M
Accounts Payable	$31M	$39M	$42M	$43M	$17M	$13M	$13M	$12M	$9M	$5M
Accrued Liabilities	$265M	$241M	$196M	$205M	$146M	$108M	$83M	$62M	$62M	$55M
Current Liabilities	$384M	$344M	$280M	$261M	$181M	$190M	$103M	$75M	$71M	$60M
Capital Leases	$24M	$30M	$31M	$20M	$30M	$39M	$30M	·	·	·
Deferred Tax	$30M	$30M	$30M	$32M	$33M	$33M	$33M	$31M	$31M	·
Other Non-current Liabilities	$44M	$17M	$12M	$5M	$1M	$7M	·	$5M	$5M	$6M
Total Liabilities	$1.60B	$1.24B	$1.22B	$1.19B	$600M	$605M	$482M	$111M	$107M	$67M
Common Stock	$0	$0	$82.0K	$70.0K	$69.0K	$67.0K	$58.0K	$51.0K	$44.0K	$41.0K
Paid-in Capital	$4.45B	$4.21B	$3.66B	$3.14B	$3.00B	$2.77B	$2.09B	$1.64B	$1.22B	$1.00B
Retained Earnings	$-4.53B	$-3.96B	$-3.39B	$-2.78B	$-2.07B	$-1.62B	$-1.43B	$-1.03B	$-833M	$-531M
Treasury Stock	$8M	$4M	$432.0K	$0	·	·	·	·	·	·
AOCI	$1M	$-1M	$647.0K	$-7M	$-1M	$689.0K	$-147.0K	$-633.0K	$-6M	$905.0K
Stockholders' Equity	$-80M	$255M	$275M	$352M	$923M	$1.15B	$654M	$609M	$383M	$474M
Liabilities + Equity	$1.53B	$1.50B	$1.49B	$1.55B	$1.52B	$1.76B	$1.14B	$720M	$491M	$541M
Shares Outstanding	96,600,000	92,500,000	82,300,000	70,200,000	69,344,998	66,818,520	57,838,220	50,860,588	44,167,071	41,240,230

Flusso di cassa 13

Dati annuali Flusso di cassa per RARE
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
D&A	$35M	$36M	$26M	$18M	$13M	$12M	$9M	$20M	$6M	$3M
Stock-based Comp	·	·	·	·	·	·	·	·	$68M	$48M
Deferred Tax	·	$-1M	$-2M	$2M	·	·	$2M	·	$-16M	·
Other Non-cash	$74M	$118M	$104M	$310M	$102M	$42M	$47M	$-112M	$-9M	$33M
Operating Cash Flow	$-466M	$-414M	$-475M	$-380M	$-339M	$-132M	$-345M	$-291M	$-254M	$-161M
CapEx	$6M	$7M	$44M	$116M	$73M	$44M	$25M	$4M	$3M	$10M
Investing Cash Flow	$236M	$-18M	$168M	$-292M	$-195M	$-179M	$-13M	$-33M	$55M	$91M
Stock Issued	·	·	·	$0	$0	$436M	$330M	$271M	·	·
Net Stock Activity	·	·	·	$0	·	$436M	$330M	$271M	·	·
Financing Cash Flow	$478M	$399M	$388M	$501M	$119M	$600M	$679M	$337M	$136M	$139M
Net Change in Cash	$252M	$-35M	$81M	$-172M	$-417M	$290M	$321M	$12M	$-62M	$69M
Taxes Paid	$4M	·	·	·	·	·	·	·	·	·
Free Cash Flow	$-472M	$-422M	$-519M	$-497M	$-412M	$-176M	$-370M	$-295M	$-257M	$-171M

Redditività 7

Dati annuali Redditività per RARE
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Operating Margin	-79.5%	-95.7%	-131.1%	-178.6%	-108.6%	-121.8%	-409.0%	-721.2%	-12593.5%	-186471.4%
Net Margin	-85.4%	-101.6%	-139.7%	-194.7%	-129.2%	-68.8%	-388.3%	-383.8%	-11567.3%	-184867.7%
Pretax Margin	-84.8%	-101.3%	-140.1%	-193.1%	-128.9%	-68.4%	-385.1%	-382.8%	-12187.5%	-184841.4%
EBITDA Margin	-74.3%	-89.3%	-125.1%	-173.6%	-104.9%	-117.3%	-400.8%	-683.2%	-12370.5%	-183897.0%
ROA	-37.9%	-38.0%	-40.0%	-46.1%	-27.7%	-12.9%	-43.4%	-32.6%	-58.6%	-44.7%
ROE	-1613.2%	-189.1%	-395.0%	-172.3%	-48.9%	-20.5%	-58.3%	-31.1%	-70.5%	-48.9%
ROIC	673.4%	-210.5%	-206.1%	-185.6%	-41.5%	-28.8%	-65.4%	-61.2%	-81.4%	-52.3%

Liquidità e Solvibilità 2

Dati annuali Liquidità e Solvibilità per RARE
Metrica	Tendenza	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Current Ratio		2.5	2.4	2.6	3.4	4.7	6.8	8.2	7.0	3.8	6.7
Quick Ratio		1.5	0.9	1.0	0.7	1.9	3.9	7.6	6.3	3.4	6.3

Efficienza 3

Dati annuali Efficienza per RARE
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Asset Turnover	0.4	0.4	0.3	0.2	0.2	0.2	0.1	0.1	0.0	0.0
Inventory Turnover	·	·	·	·	·	·	·	0.3	0.0	·
Receivables Turnover	4.8	5.7	7.6	10.6	13.6	9.7	4.6	5.7	1.0	·

Per Azione 5

Dati annuali Per Azione per RARE
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Book Value / Share	$-0.83	$2.76	$3.35	$5.02	$13.30	$17.28	$11.30	$11.97	$8.68	$11.49
Revenue / Share	$6.83	$6.19	$5.90	$5.20	·	·	·	·	·	·
Cash Flow / Share	$-4.73	$-4.57	$-6.46	$-5.44	·	·	·	·	·	·
Cash / Share	$4.36	$1.88	$2.59	$1.89	$4.44	$10.68	$7.50	$2.23	$2.28	$3.91
EPS (TTM)	$-5.83	$-6.29	$-8.25	$-10.12	$-6.70	$-3.07	$-7.01	$-3.91	·	·

Tassi di Crescita 3

Dati annuali Tassi di Crescita per RARE
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Revenue YoY	20.2%	29.0%	19.4%	3.4%	29.7%	·	·	·	·	·
Revenue CAGR 3Y	22.8%	16.8%	17.0%	·	·	·	·	·	·	·
Revenue CAGR 5Y	20.0%	·	·	·	·	·	·	·	·	·

Valutazione (TTM) 10

Dati annuali Valutazione (TTM) per RARE
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Revenue TTM	$673M	$560M	$434M	$363M	$351M	$271M	$104M	$51M	$3M	$133.0K
Net Income TTM	$-575M	$-569M	$-607M	$-707M	$-454M	$-187M	$-403M	$-198M	$-302M	$-246M
Market Cap	$2.22B	$3.89B	$3.94B	$3.25B	$5.83B	$9.25B	$2.47B	$2.21B	$2.05B	$2.90B
P/E	-3.9	-6.7	-5.8	-4.6	-12.6	-45.1	-6.1	-11.1	·	·
P/S	3.3	6.9	9.1	9.0	16.6	34.1	23.8	42.9	784.3	21801.5
P/B	-27.8	15.2	14.3	9.2	6.3	8.0	3.8	3.6	5.3	6.1
P / Tangible Book	·	117.9	61.2	22.1	7.8	9.4	·	·	·	·
P / Cash Flow	-4.8	-9.4	-8.3	-8.5	-17.2	-70.0	-7.2	-7.6	-8.1	-18.0
P / FCF	-4.7	-9.2	-7.6	-6.5	-14.2	-52.5	-6.7	-7.5	-8.0	-16.9
Earnings Yield	-25.4%	-14.9%	-17.2%	-21.8%	-8.0%	-2.2%	-16.4%	-9.0%	·	·

Conto Economico 14

Dati trimestrali Conto Economico per RARE
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue	$136M	$207M	$160M	$166M	$139M	$165M	$139M	$147M	$109M	$127M	$98M	$108M	$100M	$103M	$91M	$89M
R&D Expense	$187M	$203M	$216M	$165M	$166M	$188M	$170M	$162M	$178M	$160M	$157M	$165M	$166M	$171M	$237M	$155M
SG&A Expense	$88M	$88M	$87M	$87M	$87M	$82M	$80M	$81M	$78M	$77M	$75M	$81M	$77M	$73M	$70M	$68M
Operating Income	$-169M	$-113M	$-171M	$-108M	$-143M	$-122M	$-132M	$-116M	$-165M	$-122M	$-145M	$-148M	$-154M	$-146M	$-225M	$-142M
Interest Income	$6M	$7M	$6M	$6M	$7M	$10M	$11M	$7M	$9M	$9M	$6M	$6M	$6M	$6M	$3M	$899.0K
Other Non-op	·	$-934.0K	$-1M	$2M	$837.0K	$-5M	$3M	$-2M	$-2M	$1M	$-699.0K	$-2M	$308.0K	$180.0K	$-1M	$-930.0K
Pretax Income	$-184M	$-128M	$-180M	$-114M	$-150M	$-133M	$-133M	$-131M	$-170M	$-127M	$-159M	$-159M	$-163M	$-153M	$-239M	$-158M
Income Tax	$1M	$870.0K	$873.0K	$947.0K	$1M	$384.0K	$303.0K	$858.0K	$455.0K	$-4M	$650.0K	$732.0K	$495.0K	$-1M	$6M	$302.0K
Net Income	$-185M	$-129M	$-180M	$-115M	$-151M	$-133M	$-134M	$-132M	$-171M	$-124M	$-160M	$-160M	$-164M	$-152M	$-245M	$-158M
EPS (Basic)	$-1.84	$-1.28	$-1.81	$-1.17	$-1.57	$-1.34	$-1.40	$-1.52	$-2.03	$-1.44	$-2.23	$-2.25	$-2.33	$-2.17	$-3.50	$-2.26
EPS (Diluted)	$-1.84	$-1.28	$-1.81	$-1.17	$-1.57	$-1.34	$-1.40	$-1.52	$-2.03	$-1.44	$-2.23	$-2.25	$-2.33	$-2.17	$-3.50	$-2.26
Shares (Basic)	100,600,000	-195,920,392	99,771,297	98,460,445	96,300,000	-175,860,804	95,493,996	86,580,516	84,286,292	-139,430,962	71,664,493	70,897,991	70,368,478	-139,581,974	70,054,173	69,925,358
Shares (Diluted)	100,600,000	-195,920,392	99,771,297	98,460,445	96,300,000	-175,860,804	95,493,996	86,580,516	84,286,292	-139,430,962	71,664,493	70,897,991	70,368,478	-139,581,974	70,054,173	69,925,358
EBITDA	$-161M	·	$-171M	$-108M	$-134M	·	$-132M	$-116M	$-157M	·	$-145M	$-148M	$-149M	·	$-225M	$-142M

Stato Patrimoniale 28

Dati trimestrali Stato Patrimoniale per RARE
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Cash & Equivalents	$175M	$421M	$203M	$176M	$127M	$174M	$151M	$481M	$112M	$214M	$73M	$102M	$86M	$133M	$392M	$160M
Receivables	$121M	$158M	$113M	$124M	$99M	$122M	$93M	$106M	$100M	·	$79M	$71M	$43M	·	$31M	$37M
Inventory	$55M	$52M	$52M	$46M	$46M	$45M	$43M	$40M	$36M	·	$32M	$28M	$27M	·	$22M	$21M
Prepaid Expense	$68M	$61M	$53M	$61M	$60M	$40M	·	·	·	·	$46M	$51M	$67M	·	$71M	$77M
Other Current Assets	·	·	·	·	·	·	$41M	$55M	$48M	·	·	·	·	·	·	·
Current Assets	$657M	$951M	$643M	$720M	$699M	$817M	$800M	$965M	$596M	·	$599M	$702M	$766M	·	$1.01B	$679M
PP&E (Net)	$239M	$244M	$250M	$256M	$261M	$266M	$272M	$279M	$285M	·	$297M	$289M	$278M	·	$235M	$207M
PP&E (Gross)	·	$380M	·	·	·	$378M	·	·	·	·	·	·	·	·	·	·
Accum. Depreciation	·	$136M	·	·	·	$112M	·	·	·	·	·	·	·	·	·	·
Goodwill	$44M	$44M	$44M	$44M	$44M	$44M	$44M	$44M	$44M	·	$44M	$44M	$44M	·	$44M	$44M
Intangibles	$174M	$176M	$173M	$175M	$177M	$178M	$165M	$166M	$165M	·	$157M	$158M	$159M	·	$158M	$159M
Other Non-current Assets	$61M	$60M	$58M	$60M	$62M	$63M	$54M	$54M	$60M	·	$28M	$26M	$22M	·	$18M	$21M
Total Assets	$1.30B	$1.53B	$1.19B	$1.31B	$1.31B	$1.50B	$1.54B	$1.62B	$1.31B	·	$1.24B	$1.31B	$1.38B	·	$1.62B	$1.32B
Accounts Payable	$42M	$31M	$41M	$34M	$47M	$39M	$36M	$60M	$41M	·	$33M	$42M	$59M	·	$24M	$34M
Accrued Liabilities	$194M	$265M	$221M	$181M	$173M	$241M	$185M	$154M	$149M	·	$179M	$168M	$144M	·	$189M	$170M
Current Liabilities	$325M	$384M	$340M	$293M	$292M	$344M	$285M	$273M	$246M	·	$254M	$244M	$218M	·	$227M	$221M
Capital Leases	·	$24M	$22M	$25M	$28M	$30M	·	·	·	·	·	·	·	·	·	·
Deferred Tax	$30M	$30M	$30M	$30M	$30M	$30M	$30M	$30M	$30M	·	$32M	$32M	$32M	·	$33M	$33M
Other Non-current Liabilities	$42M	$20M	$19M	$17M	$17M	$17M	$16M	$15M	$14M	·	$10M	$10M	$9M	·	$4M	$4M
Total Liabilities	$1.52B	$1.60B	$1.17B	$1.15B	$1.16B	$1.24B	$1.18B	$1.19B	$1.17B	·	$1.21B	$1.18B	$1.16B	·	$1.15B	$643M
Common Stock	$0	$0	$96.0K	$96.0K	$94.0K	$0	$92.0K	$92.0K	$83.0K	·	$72.0K	$71.0K	$71.0K	·	$70.0K	$70.0K
Paid-in Capital	$4.48B	$4.45B	$4.41B	$4.37B	$4.25B	$4.21B	$4.17B	$4.12B	$3.70B	·	$3.30B	$3.24B	$3.17B	·	$3.11B	$3.07B
Retained Earnings	$-4.72B	$-4.53B	$-4.40B	$-4.22B	$-4.11B	$-3.96B	$-3.82B	$-3.69B	$-3.56B	·	$-3.26B	$-3.10B	$-2.94B	·	$-2.63B	$-2.38B
Treasury Stock	$10M	$8M	$8M	$8M	$8M	$4M	$4M	$3M	$3M	·	$381.0K	$381.0K	$356.0K	·	·	·
AOCI	$0	$1M	$820.0K	$-268.0K	$-341.0K	$-1M	$896.0K	$-1M	$-431.0K	·	$-2M	$-3M	$-4M	·	$-10M	$-9M
Stockholders' Equity	$-236M	$-80M	$9M	$151M	$144M	$255M	$347M	$432M	$140M	$275M	$32M	$129M	$220M	$352M	$469M	$678M
Liabilities + Equity	$1.30B	$1.53B	$1.19B	$1.31B	$1.31B	$1.50B	$1.54B	$1.62B	$1.31B	·	$1.24B	$1.31B	$1.38B	·	$1.62B	$1.32B
Shares Outstanding	98,300,000	96,600,000	96,442,027	96,353,634	93,903,785	92,500,000	92,304,317	92,135,384	83,094,037	82,300,000	72,174,307	71,465,424	70,660,249	70,197,297	70,079,777	70,010,398

Flusso di cassa 8

Dati trimestrali Flusso di cassa per RARE
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
D&A	$8M	$9M	$9M	$9M	$9M	$10M	$9M	$9M	$9M	$8M	$7M	$5M	$5M	$5M	$5M	$4M
Other Non-cash	$-20M	·	·	·	$-24M	·	·	·	$-29M	·	·	·	$2M	·	·	·
Operating Cash Flow	$-197M	$-100M	$-91M	$-108M	$-166M	$-79M	$-67M	$-77M	$-191M	$-84M	$-118M	$-116M	$-157M	$-90M	$-95M	$-77M
CapEx	$1M	$938.0K	$1M	$2M	$1M	$163.0K	$2M	$2M	$3M	$1M	$4M	$14M	$25M	$27M	$26M	$31M
Investing Cash Flow	$-49M	$-72M	$117M	$71M	$120M	$103M	$-276M	$61M	$94M	$-107M	$64M	$99M	$111M	$-172M	$-162M	$79M
Financing Cash Flow	·	$394M	$2.0K	$84M	$157.0K	$3M	$11M	$385M	$-58.0K	$330M	$25M	$33M	$-722.0K	$2M	$492M	$6M
Net Change in Cash	$-247M	$221M	$26M	$49M	$-45M	$24M	$-330M	$368M	$-97M	$140M	$-29M	$16M	$-46M	$-259M	$234M	$7M
Free Cash Flow	$-198M	·	·	·	$-168M	·	·	·	$-194M	·	·	·	$-182M	·	·	·

Redditività 7

Dati trimestrali Redditività per RARE
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Operating Margin	-124.3%	·	-106.8%	-64.8%	-102.6%	·	-94.6%	-79.1%	-151.9%	·	-148.0%	-136.6%	-153.3%	·	-248.1%	-158.5%
Net Margin	-136.0%	·	-112.8%	-69.0%	-108.5%	·	-95.7%	-89.5%	-156.8%	·	-162.8%	-147.6%	-163.2%	·	-270.2%	-177.0%
Pretax Margin	-135.3%	·	-112.3%	-68.5%	-107.5%	·	-95.5%	-88.9%	-156.4%	·	-162.2%	-146.9%	-162.7%	·	-263.3%	-176.7%
EBITDA Margin	-118.4%	·	-106.8%	-64.8%	-96.2%	·	-94.6%	-79.1%	-143.8%	·	-148.0%	-136.6%	-148.1%	·	-248.1%	-158.5%
ROA	-14.2%	·	-13.2%	-7.9%	-11.5%	·	-9.6%	-9.0%	-12.7%	·	-11.2%	-12.2%	-11.8%	·	-15.8%	-11.2%
ROE	403.2%	·	-101.4%	-39.4%	-106.2%	·	-70.5%	-46.9%	-94.6%	·	-63.8%	-39.6%	-32.2%	·	-34.9%	-19.2%
ROIC	72.0%	·	-1874.9%	-71.9%	-100.0%	·	-38.1%	-27.1%	-118.2%	·	-459.4%	-115.2%	-70.1%	·	-49.3%	-20.9%

Liquidità e Solvibilità 2

Dati trimestrali Liquidità e Solvibilità per RARE
Metrica	Tendenza	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Current Ratio		2.0	·	1.9	2.5	2.4	·	2.8	3.5	2.4	·	2.4	2.9	3.5	·	4.5	3.1
Quick Ratio		0.9	·	0.9	1.0	0.8	·	0.9	2.1	0.9	·	0.6	0.7	0.6	·	1.9	0.9

Efficienza 2

Dati trimestrali Efficienza per RARE
Metrica	Tendenza	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Asset Turnover		0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1
Receivables Turnover		1.2	·	1.6	1.4	1.4	·	1.6	1.7	1.5	·	1.8	2.0	2.8	·	3.2	2.9

Per Azione 5

Dati trimestrali Per Azione per RARE
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Book Value / Share	$-2.40	·	$0.10	$1.57	$1.54	·	$3.76	$4.69	$1.69	·	$0.44	$1.81	$3.12	·	$6.69	$9.69
Revenue / Share	$1.35	·	$1.60	$1.69	$1.45	·	$1.46	$1.70	$1.29	·	$1.37	$1.53	$1.43	·	$1.29	·
Cash Flow / Share	$-1.96	·	·	·	$-1.73	·	·	·	$-2.26	·	·	·	$-2.23	·	·	·
Cash / Share	$1.78	·	$2.10	$1.83	$1.35	·	$1.63	$5.22	$1.35	·	$1.01	$1.43	$1.21	·	$5.59	$2.28
EPS (TTM)	$-6.39	·	$-5.95	$-5.66	$-6.52	·	$-7.18	$-8.03	$-8.84	·	$-10.31	$-10.34	$-10.28	·	$-9.03	$-7.34

Valutazione (TTM) 10

Dati trimestrali Valutazione (TTM) per RARE
Metrica	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Revenue TTM	$601M	·	$605M	$592M	$535M	·	$493M	$462M	$416M	·	$398M	$389M	$360M	·	$342M	$338M
Net Income TTM	$-631M	·	$-580M	$-531M	$-587M	·	$-595M	$-622M	$-654M	·	$-729M	$-727M	$-720M	·	$-629M	$-506M
Market Cap	$2.06B	·	$2.90B	$3.50B	$3.40B	·	$5.13B	$3.79B	$3.88B	·	$2.57B	$3.30B	$2.83B	·	$2.90B	$4.18B
P/E	-3.3	·	-5.1	-6.4	-5.6	·	-7.7	-5.1	-5.3	·	-3.5	-4.5	-3.9	·	-4.6	-8.1
P/S	3.4	·	4.8	5.9	6.4	·	10.4	8.2	9.3	·	6.5	8.5	7.9	·	8.5	12.4
P/B	-8.7	·	316.7	23.2	23.6	·	14.8	8.8	27.7	·	81.1	25.5	12.9	·	6.2	6.2
P / Tangible Book	·	·	·	·	·	·	37.3	17.1	·	·	·	·	167.6	·	10.9	8.8
P / Cash Flow	-10.5	·	·	·	-20.4	·	·	·	-20.3	·	·	·	-18.1	·	·	·
P / FCF	-10.4	·	·	·	-20.3	·	·	·	-20.0	·	·	·	-15.6	·	·	·
Earnings Yield	-30.5%	·	-19.8%	-15.6%	-18.0%	·	-12.9%	-19.5%	-18.9%	·	-28.9%	-22.4%	-25.6%	·	-21.8%	-12.3%

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Conto Economico

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$673M	$560M	$434M	$363M	$351M
Margine Operativo %	-79.5%	-95.7%	-131.1%	-178.6%	-108.6%
Utile netto	$-575M	$-569M	$-607M	$-707M	$-454M
EPS Diluito	$-5.83	$-6.29	$-8.25	$-10.12	$-6.70

Stato Patrimoniale

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Rapporto corrente	2.5	2.4	2.6	3.4	4.7
Quick Ratio	1.5	0.9	1.0	0.7	1.9

Flusso di cassa

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$-472M	$-422M	$-519M	$-497M	$-412M

Ultime notizie Notizie recenti che menzionano questa società

La FDA Accetta la BLA di Ultragenyx (RARE) per la Terapia Genica UX111 per la Sindrome di Sanfilippo Yahoo Finance · 1 mese fa

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

📊

Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

RARE Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

RARE Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Medie mobili e sovrapposizioni

Volume

Oscillatori

Momentum e tendenza

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

RARE Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

Target Price a 12 Mesi

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Confronto tra pari Metriche chiave rispetto ai pari del settore

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Ultime notizie Notizie recenti che menzionano questa società

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi